HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis (NATRUL-4)
A Phase III Double Blind, Multi-Center Placebo Controlled Maintenance Trial of HMPL-004 in Subjects With Mild to Moderate Ulcerative Colitis With Clinical Remission or Response From Induction Therapy. (NATRUL-4)
Sponsor: Hutchison Medipharma Limited
Terminated
Futility interim analysis of the Induction Study HMPL-004-03.
Other terminated trials from Hutchison Medipharma Limited
- Acute Myeloid Leukemia · Phase PHASE1 · Sep 2019
- Cancer · Phase PHASE1 · Dec 2018
- Crohn Disease · Phase PHASE1 · Nov 2018
- Solid Tumor · Phase PHASE1 · Aug 2018
- Ulcerative Colitis · Phase PHASE3 · Oct 2014
More terminations from Hutchison Medipharma Limited
Other Ulcerative Colitis trials with similar outcome
This PHASE3 trial investigates Ulcerative Colitis and is currently terminated or withdrawn. Hutchison Medipharma Limited leads this study, which shows 11 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE3
-
Oct 2022 — Dec 2022 [monthly]
Terminated PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Oct 2022 [monthly]
Terminated PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Mar 2019 — Feb 2020 [monthly]
Terminated PHASE3
-
Jun 2018 — Mar 2019 [monthly]
Terminated PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hutchison Medipharma Limited
- Nutrition Science Partners Limited
For direct contact, visit the study record on ClinicalTrials.gov .